2-氯-N-(4-甲基苯基)-5-硝基苯甲酰胺 | 292638-37-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-氯-N-(4-甲基苯基)-5-硝基苯甲酰胺
• 英文名称: 2-chloro-5-nitro-N-(p-tolyl)benzamide
• 英文别名: N-(4-Methylphenyl)-(2-chloro-5-nitrophenyl)carboxamide；2-Chloro-N-(4-methylphenyl)-5-nitrobenzamide
• CAS: 292638-37-0
• 化学式: C₁₄H₁₁ClN₂O₃
• mdl: MFCD00426707
• 分子量: 290.706
• InChiKey: PCTYWHPBLLIODL-UHFFFAOYSA-N

物化性质

• 沸点：
  374.9±42.0 °C(Predicted)
• 密度：
  1.395±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  20
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  74.9
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-氯-N-(4-甲基苯基)-5-硝基苯甲酰胺 在 溶剂黄146 、 三乙胺 、 tin(ll) chloride 作用下， 以 N-甲基吡咯烷酮 、 乙醇 为溶剂， 反应 33.0h， 生成 5-(5-cyano-1,3-dioxoisoindolin-2-yl)-2-(piperidin-1-yl)-N-p-tolylbenzamide
  参考文献：
  名称：

  Structure–activity relationships for lipoprotein lipase agonists that lower plasma triglycerides in vivo

  摘要：

  The risk of cardiovascular events increases in individuals with elevated plasma triglyceride (TG) levels, therefore advocating the need for efficient TG-lowering drugs. In the blood circulation, TG levels are regulated by lipoprotein lipase (LPL), an unstable enzyme that is only active as a non-covalently associated homodimer. We recently reported on a N-phenylphthalimide derivative (1) that stabilizes LPL in vitro, and moderately lowers triglycerides in vivo (Biochem. Biophys. Res. Common. 2014, 450, 1063). Herein, we establish structure activity relationships of 51 N-phenylphthalimide analogs of the screening hit 1. In vitro evaluation highlighted that modifications on the phthalimide moiety were not tolerated and that lipophilic substituents on the central phenyl ring were functionally essential. The substitution pattern on the central phenyl ring also proved important to stabilize LPL However, in vitro testing demonstrated rapid degradation of the phthalimide fragment in plasma which was addressed by replacing the phthalimide scaffold with other heterocyclic fragments. The in vitro potency was retained or improved and substance 80 proved stable in plasma and efficiently lowered plasma TGs in vivo. 2015 The Authors. Published by Elsevier Masson SAS.

  DOI：

  10.1016/j.ejmech.2015.08.058
• 作为产物：
  描述：

  2-氯-5-硝基苯甲酸 在 草酸 、 三乙胺 、 N,N-二甲基甲酰胺 作用下， 以 二氯甲烷 为溶剂， 反应 7.33h， 生成 2-氯-N-(4-甲基苯基)-5-硝基苯甲酰胺
  参考文献：
  名称：

  [EN] NEW PLASMA LIPID LOWERING AGENTS
  [FR] NOUVEAUX AGENTS ABAISSANT LES TAUX DES LIPIDES PLASMATIQUES

  摘要：

  本发明涉及新的降低血浆脂质的化合物和药物组合物，以及它们在预防、预防和治疗高脂血症，包括高三酸甘油酯血症、高脂蛋白血症和高胆固醇血症，以及与高脂血症相关的疾病中的应用。

  公开号：

  WO2015187082A1

文献信息

• Covalent Occlusion of the RORγt Ligand Binding Pocket Allows Unambiguous Targeting of an Allosteric Site
  作者：Femke A. Meijer、Maxime C. M. van den Oetelaar、Richard G. Doveston、Ella N. R. Sampers、Luc Brunsveld

  DOI：10.1021/acsmedchemlett.1c00029

  日期：2021.4.8

  autoimmune diseases, and inhibition of RORγt with small molecules thus holds great potential as a therapeutic strategy. RORγt has a unique allosteric ligand binding site in the ligand binding domain, which is distinct from the canonical, orthosteric binding site. Allosteric modulation of RORγt shows high potential, but the targeted discovery of novel allosteric ligands is highly challenging via currently

  核受体RORγt是T辅助细胞17（Th17）细胞分化和增殖以及促炎性细胞因子（如IL-17a）产生的关键正调控因子。该途径的失调可导致各种自身免疫性疾病的发展，因此用小分子抑制RORγt具有作为治疗策略的巨大潜力。RORγt在配体结合结构域中具有独特的变构配体结合位点，其不同于典型的正构结合位点。RORγt的变构调节显示出很高的潜力，但是通过目前可用的方法，靶向发现新的变构配体具有很高的挑战性。在此，我们介绍RORγt的共价正构化学探针，该探针封闭正构，正构配体的结合，但仍允许变构配体结合。
• PPAR-gamma modulator
  申请人：SANKYO COMPANY, LIMITED

  公开号：US20030134859A1

  公开（公告）日：2003-07-17

  A compound of the following formula or a pharmacologically acceptable salt thereof: 1 wherein A represents a phenyl group or the like, B represents an aryl group or the like, X represents an oxygen atom or the like, and n represents 0 or 1. The compound is a PPAR &ggr; modulator which is a therapeutic agent for retrograde osteoporosis in which excessive differentiation of adipocytes is inhibited and formation and differentiation of osteoblasts from stem cells is facilitated, and for diabetes mellitus without characteristics such as excessive adipogenesis, liver dysfunction, vascular disorders, heart diseases and the like.

  以下化学式的化合物或其药理学上可接受的盐：其中A代表苯基或类似物，B代表芳基或类似物，X代表氧原子或类似物，n代表0或1。该化合物是一种PPAR &ggr; 调节剂，用于治疗逆行性骨质疏松症，通过抑制脂肪细胞的过度分化并促进干细胞向成骨细胞的形成和分化，以及用于糖尿病而不具有过度脂肪生成、肝功能障碍、血管紊乱、心脏疾病等特征。
• [EN] NEW PLASMA LIPID LOWERING AGENTS<br/>[FR] NOUVEAUX AGENTS ABAISSANT LES TAUX DES LIPIDES PLASMATIQUES
  申请人：LIPIGON PHARMACEUTICALS AB

  公开号：WO2015187082A1

  公开（公告）日：2015-12-10

  The present invention relates to new plasma lipid lowering compounds and pharmacological compositions,and their use in the prophylaxis, prevention and treatment of hyperlipidemia, including hypertriglyceridemia, hyperlipoproteinemia, and hypercholesterolemia, as well as hyperlipidemia-related diseases.

  本发明涉及新的降低血浆脂质的化合物和药物组合物，以及它们在预防、预防和治疗高脂血症，包括高三酸甘油酯血症、高脂蛋白血症和高胆固醇血症，以及与高脂血症相关的疾病中的应用。
• One Pot Regioselective Synthesis of a Small Library of Dibenzo[<i>b</i>,<i>f</i>][1,4]thiazepin-11(10<i>H</i>)-ones via Smiles Rearrangement
  作者：Yongmei Zhao、Qiaoling Dai、Zhi Chen、Qihui Zhang、Yongcheng Bai、Chen Ma

  DOI：10.1021/co300139s

  日期：2013.2.11

  A facile and efficient method has been developed for the synthesis of a small library of dibenzo[b,f][1,4]thiazepin-11(10H)-ones via Smiles rearrangement. Compounds were obtained in excellent isolated yields (70%–92%) under metal-free conditions. More specifically, this transition metal-free process relates to an environmentally friendly, economical, and efficient method for preparing benzoic-fused

  已经开发了一种通过Smiles重排合成小的二苯并[ b，f ] [1,4] thiazepin-11（10 H）-ones小型文库的简便有效方法。在无金属条件下，化合物的分离产率极高（70％–92％）。更具体地说，这种无过渡金属的方法涉及制备苯并稠合的七元内酰胺的环保，经济和有效的方法。
• Base-promoted direct amidation of esters: beyond the current scope and practical applications
  作者：Ivaylo Slavchev、Jas. S. Ward、Kari Rissanen、Georgi M. Dobrikov、Svilen Simeonov

  DOI：10.1039/d2ra03524c

  日期：——

  the full potential of this transformation is yet to be revealed by broadening the substrate scope. In a search for new practical applications of the amidation reaction, herein we present a comprehensive study of a number of base-promoted direct amidations that encompass a wide range of amines and esters. Furthermore, we applied our findings in the synthesis of phosphoramidates and several industrially

  未活化酯的碱促进直接酰胺化是当代有机化学中酰胺键形成最有用的反应之一。该领域的深入研究催生了许多新方法来实现这一转变。然而，迄今为止，现有文献更多的是方法论，并且在许多情况下缺乏实践指导。因此，这种转变的全部潜力还有待通过扩大底物范围来揭示。为了寻找酰胺化反应的新实际应用，本文对一系列碱促进的直接酰胺化反应进行了全面研究，这些直接酰胺化反应涵盖多种胺和酯。此外，我们将我们的发现应用于氨基磷酸酯和几种工业相关产品的合成中。